Latoya Coward
Family · Paragould, ARNPI 1184903023
Payments from drug & device makers
Across 691 payments — averaging $15.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$2K
- Novo Nordisk$1K
- AbbVie$1K
- Takeda Pharmaceuticals U.S.A., Inc.$972
- Pfizer$698
- Amgen$540
- plus $3K from 27 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 87 | $2,240 |
| Novo Nordisk | 107 | $1,459 |
| AbbVie | 105 | $1,343 |
| Takeda Pharmaceuticals U.S.A., Inc. | 57 | $972 |
| Pfizer | 55 | $698 |
| Amgen | 46 | $540 |
| GSK | 35 | $466 |
| Lilly USA, LLC | 43 | $454 |
| Astellas Pharma US Inc | 16 | $263 |
| Biohaven Pharmaceutical Holding Company Ltd. | 16 | $259 |
| Otsuka America Pharmaceutical, Inc. | 13 | $249 |
| Bayer | 12 | $199 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 14 | $196 |
| Lundbeck LLC | 8 | $147 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 7 | $135 |
| Novartis | 9 | $129 |
| Merck | 9 | $112 |
| Abbott | 6 | $109 |
| Amarin Pharma, Inc. | 7 | $107 |
| Idorsia Pharmaceuticals US Inc | 5 | $65 |
| Biohaven Pharmaceuticals, Inc. | 4 | $59 |
| Phathom Pharmaceuticals, Inc. | 6 | $52 |
| Boehringer Ingelheim | 4 | $50 |
| Eisai Inc. | 3 | $44 |
| Sumitomo Pharma America, Inc. | 3 | $43 |
| Genentech USA, Inc. | 3 | $41 |
| Sanofi Pasteur Inc. | 2 | $36 |
| Grifols USA, LLC | 3 | $36 |
| Sanofi-aventis U.S. LLC | 2 | $25 |
| Mylan Pharmaceuticals Inc. | 1 | $18 |
| Dexcom, Inc. | 1 | $15 |
| Xeris Pharmaceuticals, Inc. | 1 | $15 |
| Boston Scientific | 1 | $13 |
How this compares
$10,584 in reported general payments places this provider in the 95th percentile of 2,103 family providers in Arkansas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other family in Paragould
- Cecil MasseyParagould$13K
- Teresa GonzalezParagould$12K
- Leah CarringtonRogers$1.6M
- Nina CopelandFort Smith$207K
- Stefanie BrackinJonesboro$51K
- Amanda DavisFort Smith$46K
- Allison HittManila$40K
- Kimberly GatesNorth Little Rock$31K
- Meghan MallettConway$25K
- Anthony EcholsLittle Rock$25K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.